Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for 111, Inc. Sponsored ADR (YI : NSDQ)
 
 • Company Description   
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.

Number of Employees: 1,238

 
 • Price / Volume Information   
Yesterday's Closing Price: $7.43 Daily Weekly Monthly
20 Day Moving Average: 11,925 shares
Shares Outstanding: 8.64 (millions)
Market Capitalization: $64.22 (millions)
Beta: 0.44
52 Week High: $12.90
52 Week Low: $4.15
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -11.76% -15.68%
12 Week 8.47% -7.36%
Year To Date 19.26% 11.71%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3-4/F NO.295 ZUCHONGZHI ROAD PUDONG NEW AREA
-
SHANGHAI,F4 201203
CHN
ph: 86-21-2053-6666
fax: -
ir@111.com https://corporate.111.com.cn
 
 • General Corporate Information   
Officers
Junling Liu - Chief Executive Officer and Co-Chairman of the Boa
Gang Yu - Co-founder and Co-Chairman
Yang Chen - Director
Nee Chuan Teo - Director
Jian Sun - Director

Peer Information
111, Inc. Sponsored ADR (HLIS)
111, Inc. Sponsored ADR (AZTA)
111, Inc. Sponsored ADR (APYI)
111, Inc. Sponsored ADR (RNVA)
111, Inc. Sponsored ADR (HMSY)
111, Inc. Sponsored ADR (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 68247Q201
SIC: 5912
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 09/04/25
Share - Related Items
Shares Outstanding: 8.64
Most Recent Split Date: 1.00 (0.10:1)
Beta: 0.44
Market Capitalization: $64.22 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 09/04/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 0.03
EPS Growth
vs. Year Ago Period: 0.00%
vs. Previous Quarter: -400.00%
Sales Growth
vs. Year Ago Period: -0.48%
vs. Previous Quarter: -7.74%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -2.45
12/31/24 - -2.24
Current Ratio
06/30/25 - -
03/31/25 - 1.14
12/31/24 - 1.13
Quick Ratio
06/30/25 - -
03/31/25 - 0.53
12/31/24 - 0.54
Operating Margin
06/30/25 - -
03/31/25 - -0.48
12/31/24 - -0.45
Net Margin
06/30/25 - -
03/31/25 - -0.48
12/31/24 - -0.45
Pre-Tax Margin
06/30/25 - -
03/31/25 - -0.17
12/31/24 - -0.14
Book Value
06/30/25 - -
03/31/25 - -10.75
12/31/24 - -10.43
Inventory Turnover
06/30/25 - -
03/31/25 - 9.51
12/31/24 - 9.36
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©